Message From The President And CEO
Since joining Moffitt nine years ago and becoming the Cancer Center’s president and CEO in 2012, my enthusiasm for pursuing our mission to contribute to the prevention and cure of cancer has only grown stronger. As I talk with Moffitt faculty and staff, I find the same heartfelt commitment.
The reasons for this dedication are many, and I believe they all stem from the growing excitement centered on our scientific discoveries, coupled with better patient outcomes…all making this Cancer Center your best chance for beating cancer.
As the only National Cancer Institute (NCI) Comprehensive Cancer Center based in Florida, Moffitt is at the forefront of developing and translating scientific knowledge from promising laboratory discoveries into new treatments for cancer patients. Within our disease-specific clinical programs, we enlist a team of experts from multiple disciplines to provide each of our patients with the right personalized treatment plan. Moffitt also plays a vital role in training oncologists, a specialty predicted to experience shortages in coming years. Moffitt is training more oncologists than all other Florida institutions combined and is the state’s only training site for surgical oncologists.
I hope you will enjoy reading this annual report. The selected stories highlight some of our many efforts to perform scientific research that promises to lead the way to more clinical trials and more personalized treatments that continue to improve outcomes for our patients. The features also depict our efforts to provide the highest levels of patient care.
One such Moffitt initiative, Clinical Pathways, is a systematic tool designed to help physicians improve cancer care with the aim of achieving better patient outcomes and moving Moffitt closer to a cure for even more patients. The interactive program is a tool for Moffitt partners, linking to a variety of information, including clinical literature and outcomes data, and outlining a consistent approach to personalizing patient care and identifying relevant clinical trials.
In line with our commitment to excellence, Moffitt’s Centers of Excellence continue to bridge scientific discoveries with clinical delivery of new drugs and technologies, ultimately benefiting cancer patients. Two of the three Centers of Excellence focus on melanoma and lung cancer. Among the goals of the Center for Infection Research in Cancer, established in 2012, are to identify infectious agents that cause cancer and to translate that knowledge into effective strategies for prevention and treatment.
To accommodate Moffitt’s continuing growth, we are expanding our campus located on North Malcolm McKinley Drive in Tampa. Phase I involves the construction of a $74.2 million, 200,000-square-foot, six-story outpatient facility. You will find more details in the report of the developments that will help bring us closer to our patients and closer to a cure.
My thanks to all of you who make our progress possible — faculty, staff, donors, Board members and, most importantly, our patients and their loved ones. Thank you for joining us as we gain momentum in our fight to eliminate cancer.
Alan F. List, M.D.
President and Chief Executive Officer
Moffitt Cancer Center
Fiscal Year 2012 Financial Information
Download PDF file of Moffitt Cancer Center’s 2012 Annual Report
2012 Annual Report Contents
Honors And Awards Highlight Dedication
Centers Of Excellence Raise The Bar For Translational Research
HRI Platform Brings Scientists, Doctors Closer To Patients
Clinical Pathways Are Designed To Improve Care
NCI Provocative Question Addresses Resistance
Novel Automated Measure Of Breast Density
McKinley Campus Evolves, Expands
Precision Molecular Diagnostics Laboratory Analyzes Rare Molecules
Expanded Website Enhances Communications